AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 39 filers reported holding AGILE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $761,000 | -18.3% | 133,488 | 0.0% | 0.03% | -28.6% |
Q3 2016 | $932,000 | -8.3% | 133,488 | 0.0% | 0.04% | -20.8% |
Q2 2016 | $1,016,000 | +22.6% | 133,488 | 0.0% | 0.05% | -3.6% |
Q1 2016 | $829,000 | -36.4% | 133,488 | 0.0% | 0.06% | -33.7% |
Q4 2015 | $1,303,000 | +44.8% | 133,488 | 0.0% | 0.08% | +40.7% |
Q3 2015 | $900,000 | -21.5% | 133,488 | 0.0% | 0.06% | -1.7% |
Q2 2015 | $1,147,000 | -7.3% | 133,488 | 0.0% | 0.06% | +7.1% |
Q1 2015 | $1,237,000 | +54.2% | 133,488 | +2.2% | 0.06% | +43.6% |
Q4 2014 | $802,000 | +267.9% | 130,644 | +337.7% | 0.04% | +254.5% |
Q3 2014 | $218,000 | +14.1% | 29,850 | +36.0% | 0.01% | +22.2% |
Q2 2014 | $191,000 | – | 21,950 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 15,919,925 | $33,113,000 | 0.42% |
INVESTOR AB | 3,510,189 | $7,301,000 | 0.26% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $1,529,000 | 0.21% |
FIRST MIDWEST BANK TRUST DIVISION | 578,864 | $1,204,000 | 0.17% |
PREMIER ASSET MANAGEMENT LLC | 224,559 | $467,000 | 0.08% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 100,000 | $208,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 140,015 | $291,000 | 0.05% |
NEXPOINT ASSET MANAGEMENT, L.P. | 25,000 | $52,000 | 0.01% |
Kalos Management, Inc. | 19,250 | $35,000 | 0.01% |
Founders Capital Management | 5,000 | $10,000 | 0.01% |